
Medical Oncologist @CUH_NHS | Clinical Trialist @LabcorpDrugDev | #Cancer #Research Views personal
Cambridge, UK
Joined May 2020
- Tweets964
- Following674
- Followers427
- Likes9.8K
Pinned Tweet
Will complex, individualized therapies for cancer such as CAR-Ts be manufactured at the patients bedside in future?
Our editorial in @Annals_Oncology appeared in print on 1 Jan 2022.
annalsofoncology.org/article…
@FAndreMD @barlesi @OncoAlert
KS Saini, MD retweeted
#LineOfTherapy in Oncology Practice being elegantly presented by dear colleague and friend @KSainiMD for #ESMO22 !
KS Saini, MD retweeted
Self/evident to most, but ignored by those who need to know this fact the most.
Having trouble counting "Lines of Therapy" in a standardized way across all solid #cancers?
Here is some guidance:
nature.com/articles/s41416-0…
@OncoAlert @BrJCancer @NaturePortfolio
1
KS Saini, MD retweeted
25+ quality papers & reviews converge on the fact that increasing natural light exposure (especially in first 1-3 hrs of the day) + limiting bright artificial light 10pm-4am can improve mood, offset myopia, improve glucose tolerance, testosterone, estrogen and melatonin profiles.
KS Saini, MD retweeted
Investment in #Science counts. A data snapshot of China, India and US in @the_hindu today.
🔴 What does this mean for India in the years ahead ? Would like to hear your thoughts.
KS Saini, MD retweeted
DYK: Shift in Lung cancer staging in COVID likely 'increase in lung cancer mortality in the next few months and years, as consequence of stage shift at diagnosis associated with the COVID-19 pandemic'. tlcr.amegroups.com/article/v…
KS Saini, MD retweeted
Preventing infections during cancer therapy can be troublesome at times. However, appropriate precautions may be helpful in preventing them. Useful tips from cdc.gov/cancer/preventinfect… #cancersurvivormonth
KS Saini, MD retweeted
DYK: Cancer is one of the foremost causes of 'Financial toxicity is a term used to describe the harmful effect of high cost of treatment on a person’s quality of life. It may also be described as financial burden or financial distress.' @ChipFoundation jamanetwork.com/journals/jam…
KS Saini, MD retweeted
Finally it’s time for the #DESTINYbreast04 trial at #ASCO22 plenary session: so excited to be in the 2nd row of this big room to see such unprecedented results in the #BreastCancer field...this will remain one of the most important moment in the history of this disease
@OncoAlert
Calling all our friends and colleagues to consider making the Springer journal Oncology and Therapy a home for your manuscripts. Friendly and responsive editorial team! Quick peer review decision. PubMed indexed. Open Access. @OncoAlert @SpringerNature @Oncology_Ther
We are pleased to welcome @KSainiMD to the Editorial board of Oncology and Therapy. He has been an invaluable member of the Advisory board with the journal so we are delighted he has agreed to take up this new role.
KS Saini, MD retweeted
< 50% of cancer meds on the WHO model list of essential medicines are currently available in LMICs. Needless to say it costs lives.Proud to be part of the leadership of UICC to spearhead efforts to address this challenge . “ATOM”launch Sunday in Geneva .
KS Saini, MD retweeted
Fun fact! The name Ki67 derived from the city of Kiel (Ki) where the antibody was produced in the university department of pathology and refers to the number of the original clone (67). #Ki67
KS Saini, MD retweeted
We represent one of the most trusted professions in the world! That comes with tremendous responsibility.. nejm.org/doi/full/10.1056/NE… @NEJM @OncoAlert
KS Saini, MD retweeted
Incredibly excited to share our paper ‘Somatic mutation rates scale with lifespan across mammals’ now published @nature.
nature.com/articles/s41586-0…
An illustrated & updated tweetorial… [1/24]
KS Saini, MD retweeted
Precision cancer prevention is the new kid on the block-eminently appropriate. Loved yhh hie four pillar approach in the wonderful infographic. @NCIprevention sciencedirect.com/science/ar…
KS Saini, MD retweeted
❓How can we maximize the clinical utility of genomic testing for patients with cancer?
✅Education
✅Standardization
✅Guidelines and resources
✅Access to treatment
✅Clinical trials
ascopubs.org/doi/full/10.120……
@kevinpunie @BenWestphalen
#PrecisionMedicine 🧬🎯💊






























